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Parkinson Disease (PD) is the second most common neurological disease after Alzheimer. 
There is a need for long term monitoring to determine with higher accuracy the stage of the 
disease and regulate the levodopa treatment. Current wearable technology can achieve this 
monitorization of the patient’s daily life. Motor symptoms of the disease are the most evident and 
thus, the easiest to target and to relate to the stage of the disease. They are also the ones that 
suppose the highest impediment for the patients to perform their daily living activities. 
In this study, motor symptoms are assessed via pressure sensitive insole and gyroscopic 
sensors placed on the wrists. Eight subjects were analyzed, four controls and four with different 
stages of PD, performing a 20-step walking test. 
Pressure sensitive insole showed the transfer of force in the foot during the gait cycle. These 
signals showed the level of pronation and supination of each step. The force applied against the 
ground was reduced in subjects with PD, and specially seen in the toe-off phase which translate 
in a reduction in the ankle force. There was no apparent change in the step time in any of the 
signals. 
Gyroscopic data evaluation consisted in time domain, frequency domain and spectrogram 
analysis and comparing the Root Mean Squared (RMS) value and entropy of the signals with the 
stages of the disease to see any correlations. These procedures were made with the signals 
measured in the three axes and with the calculated angular velocity vector module. The analysis 
showed that the tremor could be visualized and the effects of bradykinesia were visible in the 
signals while walking. RMS and Entropy values didn’t show significance correlation between the 
stages of PD and their values with the exception of the RMS values of the signals in the Y axis 
and of the vector module. Tremors appeared in the frequency domain in the form of peaks at 5 
Hz that were constant through the test, as shown by the spectrograms. The frequency domain of 
the vector module had the same peaks as the rest of the signals but at the double of their 
frequency. 
Since all the signals correspond to a different person from simple tests, there was no way of 
assessing the effects of the different stages of the disease in the same individual over time. 
Wearable technology supposes a good viable solution to the problem of long-term daily 
monitoring for patients with PD. Suunto Movesense ® gyroscope sensors and Smart insole 
Forciot ® suppose a good of non-invasive monitoring technology that can provide long term daily 
data with minimal discomfort while assessing motor disfunctions that alter the movements of a 
patient. 
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1. INTRODUCTION 
Parkinson's disease (PD) is the second most common neurodegenerative disorder after 
Alzheimer’s disease with a lifetime incidence of approximately 2 percent, currently af-
fecting around 10 million people [1]. The prevalence of the disease in industrialized coun-
tries is approximately 0.3% looking to the whole population and around 1% of third age 
which means people over 60 years old. PD is an age-related disease: In population under 
50 it is very uncommon and for people in the highest age groups it can get up to 4%. [2] 
It is significantly difficult to diagnose PD when the disease is still in its early stages and 
if it’s only assessed in a single point in time. Diagnosis accuracy can be improved by 
long-term follow-up, when the symptom progression and effects of levodopa therapy can 
be monitored [2]. Early detection is key to develop an effective treatment, monitor the 
symptoms of the beginning of the disease and treat the secondary health issues that 
come with it. 
Issues monitoring the disease come from the variability the motor and non-motor impair-
ments from each patient and thus, they should be evaluated in the context of each pa-
tient’s lifestyles needs and goals [3]. The progress of the disease has different timelines 
from person to person and there is a daily change in the symptom manifestation. The 
severity may vary from day to day or even in the same day. The problem with these 
changes is that they are difficult to monitor during relatively short appointments at the 
neurology policlinic. During these follow ups, symptoms are visually analyzed by the 
neurologist, so there is no objective way of monitoring the amount or severity of the 
symptoms and the diagnosis relies entirely on the specialist. Since the monitoring of the 
PD patients is based on subjective assessment, the full range of symptoms may not be 
visible during short appointments. Thus, objective home-monitoring systems for Parkin-
son’s disease to maintain and effective treatment plan are needed. 
Wearable sensors can provide significant information for remote monitoring of PD pa-
tients. That way, every time there is a deterioration on the symptoms, the frequency and 
the intensity of them can be recorded to assess the variation of the health, how he/she 
is responding to the treatment dosage and if any increase/decrease of it is needed. Thus, 
an improvement of the monitoring of the patient is needed and developing new cost-
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effective, non-invasive technology to do so is essential to improve patient’s life quality 
and extend his lifetime. 
The Käveli project made a study during 2018 of monitoring PD patients using wearable 
technology in the form of a pressure detection insole, gyroscopic sensors attached to the 
wrist and a smartphone. This thesis aims to visualize the data from a 20-step test per-
formed by the subjects. The goal was to interpret the signals from 4 subjects in different 
stages of PD and 4 controls, observe how the development of the disease affects the 
signals and extract some features that can be used to distinguish the symptoms and their 
severity in order to make the data understandable by healthcare professionals.  
Data was collected from the insole and the gyroscopic sensors previous to this thesis 
and it was read thanks to a code provided in advance by Ville Vianto. The processing 
and analysis of the signals was done independently during the thesis. Pressure data was 
analyzed in time and animations were made to visualize the force transfer through the 
insole. Angular velocity data was analyzed both in time and frequency and extra features 
were extracted such as RMS and spectral entropy values. The results obtained with PD 
subjects were compared to the controls to see how the signals were affected by the 
different stages of the disease in different subjects. 
The work presented in this thesis starts with the background including the Parkinson’s 
disease and supervision techniques using wearables. The second section explains the 
materials and methods organized according to the type of data that was being pro-
cessed. The third section discusses the results obtained and argues about the origin of 
the signal variation. This section is divided in two parts: the first one describes the results 
of the pressure sensors and the second one of the angular velocity signal. This last part 
is again divided in several sections depending on the type of analysis performed. The 
last part summarizes the thesis and ads a conclusion to it. 
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2. BACKGROUND 
2.1 Parkinson’s disease 
There are four main dysfunctions associated with PD: Tremor at rest, Rigidity, Akinesia 
(or bradykinesia) and Postural instability. All together, they can be named as TRAP. Par-
kinsonism has also other features such as freezing due to motor blocks and fixed posture 
[3]. PD can be defined, if only looking to the motor symptoms, as bradykinesia in com-
bined with rigidity, tremor at rest or the three of them together [3]. 
Postural tremor has been seen in many PD patients and it has the exact same features 
of the essential tremor or rest tremor but sometimes it can be more disabling than the 
other two and can be considered one of the first features manifested by the disease [3]. 
Rest tremor varies from 4 to 6 Hz and it happens only in a fully resting limb. It usually 
stops when the movement starts. Rest and kinetic (during movement) tremors by them-
selves are not enough to diagnose PD.[3] 
Rigidity is characterized by increased movement resistance independently to its velocity 
(“lead‐pipe” resistance) [3], usually together with the “cogwheel” phenomenon [3]. “Cog-
wheel” phenomenon occurs when the muscle is stiff, but, when at rest, tremors happen 
[19]. In the end, rigidity can cause a failure to relax. If “cogwheel” phenomenon occurs 
without the “lead-pipe” resistance, it is not considered as rigidity [3]. One instance in 
which it is manifested is in the freezing of gait (FOG). FOG is defined as “brief, episodic 
absence or marked reduction of forward progression of the feet despite the intention to 
walk.”[22]. This includes problems initiating gait, problems turning and “destination hes-
itation” and times were the movement is achieved by dragging the feet and moving them 
few centimeters or even millimeters [22]. Something special about FOG is that PD pa-
tients with FOG can overcome it with the aid of auditory or visual cues [23]. 
Bradykinesia refers to slowness of movement and lower amplitude and speed [3]. It is 
the most characteristic clinical feature of PD. It includes difficulties with planning, initiat-
ing and executing movement and with performing sequential and simultaneous tasks. 
The reduction in the pace of the movements when performing daily living activities and 
the stretching of the reaction times can be seen as an initial manifestation of this specific 
feature. Other manifestations include loss of spontaneous movements and gesturing, 
drooling because of impaired swallowing, monotonic and hypophonic dysarthria, loss of 
facial expression (hypomimia), decreased blinking, and reduced arm swing while walk-
ing. This feature is the easiest to assess without any specific tests or formal neurological 
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examination [4]. The evaluation of bradykinesia commonly consists in several motor tests 
that have the patients perform fast repetitive movements according to the MDS-UPDRS. 
This task can be hand movements, pronation and supination or finger, toe and foot taps 
[3] Most likely slowness and a decrease in the amplitude of the movements would be 
observed. [3] 
Electromyographic analysis revealed that bradykinesia causes an inability to stimulate 
the muscles needed to provide sufficient strength to start or keep large fast movements. 
These large movements are accomplished by multiple stimulation of the agonist muscle 
as a consequence of the reduction of the electromyographic activity caused by PD. [5] 
Late stages of the disease can cause the loss of postural reflexes that usually causes 
postural instability and it mostly happens after other parkinsonism features have already 
appeared. There is a test that has the patients being pulled back and forth called “pull 
test”. It tests how the patient respond in terms of retro/propulsion to try to counteract the 
movements. The abnormal postural response would consist in taking more than two 
steps to keep balance or the absence of any response at all [3]. Postural instability is not 
considered as criteria for Parkinsonism by the Movement Disorder Society (MDS) [3]. 
Rather than tremor or bradykinesia, postural instability is the main cause of falls in PD 
patients [6] and thus, can lead to injuries such as broken hips. This PD feature is influ-
enced by many other factors such as sensory changes related to age, other PD features, 
the capability to process different sensory inputs (kinesthesia) and orthostatic hypoten-
sion. [3] [7] 
There are some abnormalities that can cause the same motor symptoms observed in 
PD. The detection of this anomalies would rule out the possibility of PD. Some of these 
features would be cerebellar abnormalities, absence of response to high levodopa dos-
age, motor symptoms showing exclusively to the lower limbs, etc. [3]  
PD patients are usually capable to perform simple tasks relatively easy but, when trying 
to perform simultaneous or motor cognitive tasks, they usually find it more difficult. Such 
is the case when walking straight in contrast with, for example, walking and turning. 
Overall there is a difficulty in movement performance which becomes slow and under 
scaled in size. This is called hypokinesia [12]. Hypokinesia, akinesia (absence of move-
ment) and dyskinesia (involuntary movements) affect PD gait. The first one is much more 
common to produce gait disturbances than the other two [12].  
One big problem that hinders early diagnosis is that the patient is only referred to the 
neurologist only when the symptoms are actually visible for themselves or family mem-
bers. A diagnostic test for PD that is trustworthy and easily applicable is not yet available. 
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Motor symptoms are the most common and detectable signs that can be assessed for 
both diagnosis and for evaluating the effectiveness of the treatments.[3] 
Advance medical imaging techniques such as SPECT (Single Photon Emission Com-
puterized Tomography), PET (Positron Emission Tomography) or CT (Computerized To-
mography) are useful to diagnose PD and rule out other possible cause of the symptoms, 
such as brain tumors, but they require specific settings only achieved in special places 
such as hospitals. With time these techniques have become more advanced and more 
accessible to use but they are still not useful enough for population-based epidemiolog-
ical research. This is the reason why the clinical symptoms are still the base of PD epi-
demiological studies. Therefore, at least two out of the four main motor symptoms are 
required to diagnose parkinsonism by the current criteria standards. [2] 
Doctor’s appointments are usually short and due to the variation on the symptoms men-
tioned before, he may not get the full scope of the disease. During these meetings, the 
doctor tries to get some feedback from the patient about his daily life to get some infor-
mation about how the treatment is working. In some cases, patients may have memory 
issues or other cognitive problems and may struggle to do so. 
Treatment assessment has the same problem since it sometimes depends on how the 
symptoms are described by the patient and how the doctor sees the patient. Therefore, 
there is no way to mathematically optimize the medication timing. This is why remote 
monitoring could give additional information useful to modify this timing. 
2.2 Wearable sensors used for monitoring Parkinson’s disease 
Previous analyses of PD gait show specific features of the distorted walking. Reduced 
or absent arm swing, reduced trunk rotation, forward stooped posture, slowness, re-
duced footstep size, decreased ground clearance, excessive hip and knee flexion and 
reduced amplitude motion at the hips, knees and ankles are some of the hallmarks of a 
parkinsonian gait [13] [14]. Reduction of stride length is the most prominent feature of 
the gait of PD patients which comes together with lower walking speed and a longer 
duration on the double-support phase [15]. Several studies proved that patients were 
able to correct spatiotemporal and kinematic parameters with the aid of external cues 
but the forces measured stayed abnormal: at push-off, the ankle power generation 
stayed reduced, however they didn’t use wearable sensors but rather video recordings 
and pressure plates [15] [16].  
There are many examples of the use of wearable devices to assess PD motor symptoms. 
For example, there is a study that analyzed the plantar force distribution in PD patients 
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using a pressure sensitive insole. When comparing the data to the controls, they noted 
that there was an increase at the midfoot load in the patients affected with the disease 
[17]. In other instances in which the focus of the study has been detecting FOG using 
inertial sensors mounted on wrists and ankles [20][21][25]. 
Tremor effects have been measured several techniques. Rissanen et al. extracted sev-
eral characteristics from this feature using inertial sensors attached to the wrist [11].An-
other type of analysis was performed by Donghee Son et al.[24]. They used nanotech-
nology-based patches that sensed muscle activity. These devices were used to detect 
different tremor frequencies in PD patients to help monitoring the disease. 
Inertial sensors (accelerometers and gyroscopes) have also been used to detect the 
effects of bradykinesia in several studies. These have been placed in several body parts 
such as the lower back, ankles and wrists [25][26][27]. Triaxial accelerometer measure-
ments have been utilized to assess bradykinesia in the sleep and showed that the motor 
features happened during the sleep at very early stages of the disease development [28]. 
Other studies have developed wearable devices that measure gait parameters such as 
stride length, heel strike and toe off angle, toe clearance, etc. [18]. In their study, Johan-
nes et al. used inertial sensors laterally strapped on both shoes. One problem regarding 
their approach is that it can cause discomfort to some patients because of the devices 
size. With the devices used in the Käveli project, discomfort is minimal since there 
shouldn’t be any problems wearing a watch-like sensor and an insole. More studies re-
garding the gait cycle in PD were performed by Del Din et al. [29]. They also used triaxial 
accelerometers to study the asymmetry of the characteristics of the parkinsonian gait. 
Overall it can be said that wearable devices have been widely used in the study of motor 
symptoms of Parkinson’s disease because they seem to detect a large number of char-
acteristics. Inertial sensors deserve special mention for their spread use and the amount 
of relevant data that has been collected from them. 
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3. MATERIALS AND METHODS 
3.1 Study Material: 
This thesis is done in cooperation with the Käveli Project, which is a research consortium 
of Tampere University (previously Tampere University of Technology), Satakunta Hos-
pital District, Orionpharma Ltd, Suunto Ltd and Forciot Ltd, all based in Finland. Data 
was collected by the Käveli project during 2018 from a sample of 50 volunteer PD pa-
tients with early stage of the disease (no dyskinesia and state changes), plus 50 volun-
teer PD patients in the later stage of the disease (having dyskinesia and state changes), 
plus 50 volunteers who did not have Parkinson's disease. Background characteristics 
and stage of the Parkinson's disease has been evaluated in the hospital using a UPDRS 
questionnaires (Unified Parkinson's Disease Rating Scale; Finnish version) and a 20-
step walking test [8]. 
Suunto Movesense ® gyroscope sensors were attached to the nondominant wrist and 
the participant wore a smart mobile phone with accelerometer and gyroscope sensors 
placed on the trunk. Suunto device had a sampling frequency of 52Hz and the cell phone 
signals were resampled at 100 Hz [Figure 1] [8]. Measuring ground forces on the feet 
was done via a Smart insole Forciot ® with a sampling frequency of 50 Hz [Figure 1]. 
The device replaces the shoe insole, avoiding as much discomfort as possible.  
 
 
Figure 1. Devices used: Suunto Movesense sensor (top left), Forciot Smart insole 
(top right) and cell phone (bottom) [8] 
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Additionally, a 3-day motion screening in a free-living setting in which the subjects were 
wearing the phone during daily activities and marking down their PD medication intakes 
[8]. This part of the study was not used in this thesis. In total, 20-step walking tests meas-
ured at the clinic and a small subset of 8 subjects (4 patients and 4 controls) measured 
at the clinic with Suunto Movesense and Forciot Insole were used in this thesis. Python 
software was used for the data processing, plotting and analysis. The list of subjects 
used in this thesis is presented in Table 1. 
ID Age Weight (kg) Height (cm) Gender UPDRS5 
kav042 72 69 168 Male 4 
kav096 47 54 162 Female 2.5 
kav110 61 61 174 Male 1.5 
kav112 67 64 155 Female 3 
kav113 62 84 169 Female 0 
kav114 44 95 186 Male 0 
kav138 55 63 165 Female 0 
kav175 71 70 180 Male 0 
Both male and female performed the walking test. The age varied from 44 to 72. Weight 
varies from 54 to 95 kg, so the pressure data from the Forciot device was expected to 
vary greatly from one to another 
UPDRS is a rating scale used to give a numeric value to the symptoms of PD. They don’t 
only focus on the physical disorders, but also on cognitive impairment, hallucinations, 
depression or anxiety, for example. The numeric values vary from 0 (unilateral involve-
ment) to 5 (wheelchair or bed bound unless aided) [9]. For this work, the overall score of 
modified UPDRS (test was MDS-UPDRS) was used. 
3.2 Methods: 
First step taken was to visualize the raw data and see how it is presented in the files. 
The Forciot data was stored in an array. In the first position there was the time data and 
in the second position there were different arrays as well with the signals from the insole 
sensors. The Suunto data was stored in an array of a length of 4. The first position was 
for the time and the other three were for the axes X, Y and Z in that order. Data was 
plotted like in Figure 2. 
Table 1. Table containing all the subjects, first four with already diagnosed PD and 
the last four are controls. 
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Figure 2. First visualization of the data of patient Kav113. Time was in Unix units. 
Forciot data on top plots the 23 sensors together. Suunto data on the bottom 
plots the angular velocity in the three axes. Both plots on the left represented the 
first test and the ones on the right the second one. 
Time was converted from the Unix unit of time so 0 would be the start of the walking test. 
In order to do so in an iterative way and for easier access to the data for further applica-
tion, the data from all 8 patients was stored in a matrix where all of them had their Forciot 
and Suunto data together. Then the conversion of the time vector was applied. 
As it can be appreciated in all the plots, there is extra data at the beginning of each 
measurement that is not of any value. To solve this, the data had to be cut in order to 
only visualize the walking part of the test. In Figure 4, the difference between the cut and 
the raw data can be seen.  
For easier visualization, a function was made to access all the data and plot either all the 
patients at the same time or the desired patient. The graphs would be shown not in their 
natural order (first the Forciot and then the Suunto), but on the test order, meaning that 
the Forciot and the Suunto samples from the first test would go first and the ones from 
the second test would go second as shown in Figure 5. Matching figures for all subjects 
are in Appendix A. 
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Figure 3.  Difference between the raw (top) and cut (bottom) of the patient Kav110 
 
Figure 4. Example for subject Kav113 of how the data stored was represented. 
First and third figure come from Forciot device and second and forth from 
Suunto gyroscopes. 
In order to be able to see the signal of each axis from the Suunto device separately for 
an easy study, the code added a new function that separated the three signals as shown 
in Figure 3. 
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Figure 5. Plot of the Suunto data separately so the angular velocity can be seen in 
the three axes. 
3.2.1 Forciot data analysis: 
In order to visualize the Forciot signals better, they were plotted in a 2D matrix to be able 
to see how the force applied on each sensor changed. For that, first the position of each 
sensor on the insole was needed. Then, a grid was hand drown to see which coordinates 
would the sensors take in the matrix. Since the hand drawn grid could deform the actual 
position, the sensors were represented then in a graph paper sheet top see if the image 
resampled the original as shown in Figure 6. Since it did, the position of each sensor was 
noted. 
Then, to test the idea, the Forciot data of one patient was stored in one matrix of dimen-
sions 22x8xlength. 22x8 are the dimensions of the grid presented in Figure 6 and length 
was the longest size of all the Forciot data. All the data was loaded in the written coordi-
nates so each signal would be placed in the place of its corresponding insole sensor. 
Given the positive result, a list was created in order to have all the Forciot data placed in 
the sole matrix easily accessible and then saved. After that, the data was animated 
showed frame by frame and it can be seen how the pressure sensors of the Forciot 
device are activated during the stand phase of the gait cycle.  
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Figure 6.  Original image of the pressure sensors (left), hand drown grid over the 
original image (center) and the representation in a paper sheet (right). 
The animation worked by doing a colormap based on a sample of the Forciot insole and 
then plot the rest of the samples “on top”. This was set using the first sample as default. 
Some data was cut when the insole sample had all the sensors signals to 0. As a result, 
the colormap was created with a colorbar around 0 like in Figure 7. Every sample after 
the first would be over the colorbar limit values; the result is a binary animation with a 
0value background and values over 0’1 in the sensors. To fix this, a function was created 
that would analyze every component of every sample of the test y of the patient x (inputs) 
and give as a result the sample in which the higher value was recorded (output). Then 
that sample would be the one used to create the first colormap and the rest would be 
animated over it. That way all the values of the sensors would be in between the values 
presented in the colorbar as shown in Figure 7. 
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Figure 7. Example of a frame using the first colormap with a sample where all sen-
sor signal is equal to zero giving as a result a binary image(left). The one on the 
corrected animation (right) has a range over 200 and the binary image only goes 
from -0.1 to 0.1. 
In order to see the total input of the Forciot device, all the data from the 23 sensors was 
added for every measurement. As a result, the data is clearer and the differences be-
tween each patient can be seen, like in Figure 8. The steps were distinguishable and 
there was a clear difference between the swinging phase and the ground phase of the 
gait cycle. It could also be appreciated how there were peaks at the beginning and the 
end of the ground phase, which corresponded to the heel strike and the toe-off instants. 
 
 
Figure 8. Total Forciot input of all the sensors in the insole. 
After plotting the input signals, they were used to calculate the average time of a full gait 
cycle. For that, an algorithm was created in order to detect the beginning of every swing-
ing phase (minimum value) taking into account that there was a minimum number of 
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samples required to get to the heel strike for every subject was just above 20 samples. 
Two consecutive points measured were considered the beginning and the end of the 
cycle. 
When all sample numbers of the peak were saved, the time vector of each measurement 
was used to calculate the time it took to make one complete gait cycle and then the 
average for each test of each patient was calculated. It is also interesting to show the 
maximum input per step taken with the Forciot sensors. For that, the previous data was 
used so the steps could be separated and then from each step the highest value of the 
input was saved so then it could be averaged in every test. To see the area under each 
step they were separated and integrated each in their time intervals. 
3.2.2 Suunto data analysis 
Suunto gyroscopic sensor measured the angular velocity around the three axes like 
in Figure 10 in rad/s. It represents the velocity in which the rotation angle change in each 
axis, so when the sensor didn’t detect any rotation, the output signal stayed 0. 
 
Figure 9. Representation of the rotation around the three axes. 
It is useful to get the root mean square (RMS) of the angular velocity signal to get an 
average at which the movement of the hand happened [10]. In their study, Koop et al. 
used this value to measure bradykinesia[10]. FFT was performed for every subject and 
control and every axis separately, so differences in frequency of the signals could be 
seen in Figure 10. 
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Figure 10.  Data from Suunto represented on the left and the FFT on the right. 
X axis on top, Y axis on the center and Z axis on the bottom. Every FFT plot also 
has the RMS value of the signal. 
The spectral entropy was calculated as well for every subject, every test and every axis 
direction. It would be expected that the higher the UPDRS level, the lower the entropy 
would be because of the tremor [11]. This was expected to happen because the tremor 
is usually regular, so the signal would be less random than the subjects with lower se-
verity of the disease or the control. It has to be taken into account that all the tests were 
walking tests and thus, all of the signals oscillate in time. This can make the values lower. 
It should also be noticed that in their study, Rissanen et al. used acceleration signals and 
in this study the analyze signals are angular velocity [11]. These facts could potentially 
hinder the results. 
There are studies of PD gait analysis using wearable sensors were researchers were 
able to distinguish events of FOG using the spectrogram of the signal (among other 
measurements) [20] [21]. Thus, spectrograms of the gyroscope signals were calculated 
in order to see if the frequency is consistent in time during the test or if there are some 
differences between the controls and the subjects affected with PD as presented in Fig-
ure 11. 
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Figure 11.  Spectrogram from the Suunto signal of subject Kav110. X axis on 
top, Y axis in the middle and Z axis in the bottom. 
It also seemed relevant to see how the module of the three-dimensional vector was 
changing in time. This module was calculated taking into account that the three signals 
from the Suunto gyroscope represent at each sample the coordinates of a vector. FFT 
and spectrograms were also performed to the resulting signal and RMS and entropy 
were calculated as well. The ending result is shown in Figure 12. 
 
Figure 12. Variation of the module of the angular velocity vector in time of pa-
tient Kav110 (top), FFT of the signal (middle) and its spectrogram (bottom). En-
tropy and RMS values shown on the top graph. 
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4. RESULTS AND DISCUSSION 
From a first look to the signals [Appendix A: Figures], it can be observed how the overall 
input in the pressure sensors of the Forciot device is lower for the Subjects with PD, 
being in a range up to 150-200 N while the controls showed ranges up to 250-300 N for 
individual sensors. Referring to the angular velocity data there is also a decrease in the 
range of values in the subjects suffering PD, being the lowest for subject Kav042 (UP-
DRS 4) with a range of -75 to 75 rad/s. It is also visible how the tremor affects the Suunto 
data in the subjects with PD. In the controls, the signals that appear during each gait 
cycle are very regular for the same patient. There are many differences between each 
other but that is just because of the different walking patterns that every person has, 
hence the need for the monitoring of every subject for a personalized treatment. PD 
subjects all show irregular patterns and, in some cases, indistinguishable cycles. This is 
a direct consequence of the reduction of the arm swing caused by the disease. Not only 
the that, but for some signals it seemed that there is noise of high amplitude. This is the 
result of the tremor. It is less obvious in subject Kav110 (UPDRS 1.5) but it increases its 
intensity proportionally with the development of the disease, being most noticeable when 
the UPDRS value is 4 (subject Kav042). 
The results are explained in depth in the following sections. They are separated by the 
type of signal, either force or angular velocity. The analysis of the Suunto data is also 
divided in four different sections. All the figures are presented in Appendix A. 
4.1 Forciot Data Analysis 
In the Forciot data analysis we can look at the total input data [Appendix A, Figures: 
Forciot total input data]. There is a clear difference between the ground phase and the 
swinging phase of the gait cycle, when the measured foot was on the air and thus, no 
force was applied to the sensor. 
In the controls it can be clearly appreciated that there are two peaks in the ground phase 
that can be seen in Figure 13. The first one corresponds to the sensors place on the heel 
of the insole and they measured the heel strike and the beginning of the ground phase 
of the cycle. After that, there was a decrease in the total force in the midway and again 
an increase in the toe-off phase. This last increment was higher than the first peak and 
that is because there was an extra force that needed to be applied to propel the body 
and to perform the next step. 
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Figure 13. Total force signal from the Forciot insole of two full gait cycles of 
control subject Kav138. The two peaks corresponding to the heel strike take val-
ues of 536 and 540 N and the ones corresponding to the toe-off reach 708 and 
722 N. 
If the information of each sensor is taken separately from the same two gait cycles, like 
shown in Figure 14, it can be visualized how the activation of each one was at a different 
time of the ground phase. This corresponded to the sifting in the applied force on the 
foot, and therefore to the insole, during the swinging phase of the opposite foot in order 
to maintain balance and prepare the body to perform the next cycle. Each of the controls 
had a specific walking pattern and thus, it was reflected in the insole signal. Apart from 
these differences, all of them showed regularity on each test and all of them had the two 
peaks previously mentioned when analyzing the total input of the insole. 
In Figure 14 it can be seen how the first sensors to receive pressure are the ones of the 
heel (2-6). In this particular case, the red signal is the highest, meaning that all most of 
the force is applied to the center of the heel (4). Then the signal coming from these 
sensors decrease and the force starts to spread through the rest of the sensors. It is 
visible how in this case, the most pressure is applied to the sensor 10 (light blue) and 
then it is transferred to sensors 12 and 20 (orange and light blue) and to finish to number 
17 (pink). This is an example of how the force is differently applied through the foot in a 
healthy control, how there is an initial supination of the foot (sensor 10 activated) followed 
by a pronation (sensor 17 activated). This pattern is, again, specific for control subject 
Kav138. 
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Figure 14. Force from each sensor of the Forciot insole of two full gait cycles 
of control subject Kav138 (left) and sensor placement on the insole (right). 
When comparing the four PD subjects in Figure 15, it can be appreciated how there was 
an evolution. Subject Kav110 (UPDRS 1.5) showed some differences with the controls, 
both peaks in the ground phase can be seen in every gait cycle, first one (heel strike) 
reduced under 500 N in some cases but visible nonetheless. Subject Kav096 (UPDRS 
2.5) also showed a decrease of the force applied in both peaks, most notably in the last 
one, just before the swinging phase, which is mostly equal to the first one and in some 
instances smaller, taking values between 450 and 500 N. Subject Kav112 (UPDRS 3) 
showed no distinguishable peaks in the first 3-4 steps of both tests and after, they be-
came recognizable but smoothed. This might mean that the subject showed difficulty to 
perform correct steps at the beginning of the test. Subject Kav042 (UPDRS 4) showed 
none of the forms observed in the controls and individual peaks were not distinguishable. 
There was just an increase in the overall pressure applied to the insole and when the 
maximum force was reached, the signal simply decreased The first assumption was that 
the heel-toe movement was not achieved and that the landing happened directly con the 
midfoot. The animation clearly showed a heel-toe movement which meant that even 
though it was present, the applied forces were very limited and the power in the toe-off 
phase was reduced. 
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Figure 15. Total input from Forciot insole of all four subjects presenting PD 
disease. Kav110 (UPDRS 1.5) on the top left, Kav096 (UPDRS 2.5) top right, 
Kav112 (UPDRS 3) bottom left and Kav042 (UPDRS 4) bottom right. 
The heel-toe patterns appeared to be different from the control subjects, as shown in 
Figure 16. Usually heel sensors experienced more force in the heel contact to the ground 
that the anterior sensors in the toe of phase. The exception was subject Kav096 (UPDRS 
2.5), who showed very reduced hell force and higher pressure in the toe of phase. How-
ever, this force was reduced as well when compared to the controls. The overall progres-
sive reduction in the toe off phase in all four subjects relates to the reduced ankle power 
generated in the gait caused by the reduced muscle activation consequence of PD. 
This effect is best represented in subject Kav042 (UPDRS 4) data. When the steps had 
less “roll” in them, the weight was not correctly applied to the foot and it may have caused 
larger force at one time instances, shifting the gait pattern. Since there was no previous 
data of any of the subjects, there was no way of quantifying the variation suffered by the 
disease and how it affected the gait cycle in each specific case. 
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Figure 16. Force from each sensor of Forciot insole of all four subjects pre-
senting PD disease. Kav110 (UPDRS 1.5) on the top left, Kav096 (UPDRS 2.5) 
top middle, Kav112 (UPDRS 3) bottom left, Kav042 (UPDRS 4) bottom middle 
and location of every sensor in the insole (left). 
All these observable measurements from the pressure sensors are easily distinguishable 
in the animations so the physicians assessing the patients can see on first sight the level 
of pronation/supination and the weight distribution through the insole. A good assess-
ment would require videos from different stages of the disease development, this would 
also include video recordings before and after the levodopa treatment to see visible 
changes. 
The total input analysis that was explained in the methodology gave the results pre-
sented in Table 2. Since the data collected from the insole is highly influenced by the 
weight of the subject, the results were divided by the subject’s weight so that it could give 
a result independent of it. There is no distinguishable pattern in the step time average 
and it seems that the different stages of PD don’t affect the time step. There is only a 
relationship between the values of the different tests per patient, which suggest that the 
tests were correctly performed so there were no significant differences in between the 
them. The maximum value recorded in the insole didn’t show any correlation with the 
stage of the disease. Same seemed to happen in the area under the graph, average of 
the integrated input.  
 
 
22 
 
Subject Test 
AVG step 
time (s) 
AVG max 
input (N) 
AVG max 
input (N/Kg) 
AVG integrated 
input (N) 
AVG integrated 
input (N/Kg) 
kav110 Forciot 1 1.11 636.49 10.43 332.61 5.45 
 Forciot 2 1.11 619.42 10.15 300.12 4.92 
kav096 Forciot 1 1.07 522.04 9.67 289.99 5.37 
 Forciot 2 1.02 506.18 9.37 272.34 5.04 
kav112 Forciot 1 1.07 556.94 8.70 305.66 4.78 
 Forciot 2 1.08 581.69 9.09 395.81 6.18 
kav042 Forciot 1 1.43 678.24 9.83 417.16 6.05 
kav113 Forciot 1 0.95 894.02 10.64 419.37 4.99 
 Forciot 2 0.90 829.02 9.87 358.70 4.27 
kav114 Forciot 1 1.12 1113.10 11.72 565.84 5.96 
 Forciot 2 1.14 1164.98 12.26 589.88 6.21 
kav138 Forciot 1 0.90 730.78 11.60 261.15 4.15 
 Forciot 2 0.90 708.53 11.25 256.30 4.07 
kav175 Forciot 1 1.13 764.18 10.92 376.67 5.38 
 Forciot 2 1.12 774.27 11.06 388.30 5.55 
Observing the results in the averaged maximum input, there is a tendency to get lower 
values, the higher the PD stage. This is due to the reduction in the strength applied 
against the ground in PD patients. To establish patterns, a statistical analysis with bigger 
sample number would be needed. All the controls got higher values in both of their tests 
compared with PD subjects except for test number two of subject Kav113, which was 
lower than both subject Kav110 (UPDRS 1.5) tests. Surprisingly, subject Kav042 (UP-
DRS 4) got a higher result than subjects Kav096 and Kav112 (UPDRS 2.5 and 3 respec-
tively). There is no relationship between the area under the graph. All the data seems 
consistent between both tests except for subject Kav112. It can be inferred that the sub-
ject didn’t walk the same way in both tests. 
The lack of relation between the results portrayed in Table 2 and PD stage may be due 
to the fact that the sample size is small and the tests were performed in different subjects 
with individual walking patterns. It has been previously explained how the gait is affected 
by PD. Using the insole during longer periods of time would provide more accurate data 
and more personalized analysis, since each person has a different gait. It would be in-
teresting to see the healthy step time of each subject and see how the disease affected 
the speed of it and the frequency of the steps. Longer period of measurement would also 
provide a good input in the variation of the power applied against the floor, on the insole 
in this case. 
 
Table 2. Table containing the average step time, average max input and the average 
integral per step. The number (Forciot 1-2) refers to the test number. 
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4.2 Suunto Data Analysis 
The Suunto gyroscopic sensor was placed on the subject’s wrists and thus, the angular 
velocity measured around the three axes corresponds to the arm swing movements per-
formed in the gait cycle. These movements are caused by the shoulder flexion, moving 
the arm forward, and extension, pulling the arm backwards. Most of the subjects, angular 
velocity (AV) around the X axis was messy, with the exception of control subject Kav114, 
who showed clear patterns that repeated evenly through both tests. All control subjects 
showed similar patterns around the Y axis except subject Kav113, who showed a differ-
ent one, but consistent through both tests, reflecting his unique walking pattern. Controls 
Kav113 and Kav138 showed similar patterns around Z axis, where there are basically 
straight lines in positive and negative directions with peaks in both extremes (sometimes 
smoothed in the positive direction). Subjects Kav114 and Kav175 (also controls) also 
had similar patterns around Z axis, but differing from the other two controls. They showed 
a first peak in the positive direction and then, there was a stop in the negative oscillation 
were the signal either flattened around 0 or decreased its gradient for a moment. All 
positive gradients were straight and showed no disturbances. These results showed that 
the healthy gait cycle is not symmetric in concern with the swinging of the arms to coun-
terbalance the body movements, meaning that the shoulder flexion and extension move-
ments do not follow the same path during the gait cycle. Example of three complete 
cycles are shown in Figure 17. Rotation stayed minimal around X axis when both Y and 
Z rotations were negative and peaked when they were positive. 
 
Figure 17. Three complete gait cycles from subject Kav114. AV measured 
around X (top), Y (center) and Z (bottom) axes. 
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All the data from the subjects with PD showed signs of tremor. In subject Kav110 (UP-
DRS 1.5), tremors (even though of low amplitude) were especially visible in the X axis, 
where a cyclic pattern was barely visible. In the other two directions, tremors were not 
distinguishable and the cyclic patterns were distorted, especially around Y axis. Maxi-
mum values were achieved around the Z axis and reached the 100 rad/s, lower than all 
the controls. Amplitude of the signal around both X and Y axes was reduced as well. 
Thus, the effects of bradykinesia and rigidity, even though they were mild, were notice-
able from the first stages of the disease. 
Subject Kav096 (UPDRS 2.5) showed signs of high amplitude tremor visible in the three 
axes. The only distinguishable gait cycle appeared on the Y axis. The lack of distinguish-
able patterns and the diminished amplitude in the Y axis was a sign of a further develop-
ment of PD and the effects of rigidity, bradykinesia and tremor in a higher degree. 
Subject Kav112 (UPDRS 3) again showed even higher degree of tremor (and of higher 
amplitude) and no oscillations in both X and Y axes. Z axis was not affected as much by 
the tremor but the gait cycles were irregular and showed high changes in the direction of 
the angular velocity happened within them.  
Subject Kav042 (UPDRS 4) didn’t show any signs of oscillation whatsoever in the X axis 
measurement, only a high amplitude 5 Hz vibration caused by the tremor. Both Y and Z 
axes showed small oscillations and even repetitive patterns. While the signal around Y 
axis seemed messy and the only discernible patterns were peaks in the negative direc-
tion, the cycles around Z axis resembled the patterns that controls Kav114 and Kav175 
showed, only reduced in amplitude (100-200 rad/s in control against 40 for subject 
Kav042). This was due to bradykinesia and rigidity and also showed higher frequency 
noise due to the tremor. The uncommon results from this subject could be due to the fact 
that he presented hemiplegia had great difficulties walking so he needed a rollator to 
move. 
4.2.1 Frequency domain. 
When performing the FFT to the signals, all controls showed a high peak in the frequen-
cies around 1 Hz. This is the result of the arm swing during the gait cycle, that makes 
around one full swing cycle per second. This peak was more prominent in the Z axis in 
all the controls and was reduced around the X axis. In control Kav138 it wasn’t not no-
ticeable. All X axis measurements showed peaks at higher frequencies which implied 
that the movements in this axis were not influenced that much from the arm swing itself 
but from the different rotations that took place in different directions within the same cy-
cle. These extra peaks are different per control subject but consistent in the two tests 
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taken, meaning that they are related to the specific way of walking that each one of them 
had. 
For subject Kav110, the main peak at 1 Hz was maintained in the three axes, reaching 
its highest amplitude in the Z axis like in the controls but there was a decrease in power 
due to the effects of rigidity and bradykinesia. The tremor, as explained in the previous 
section, was mostly noticeable in the X axis but, since It had a really low amplitude due 
to the early stage of PD, there are several smaller peaks at higher frequencies. 
Subject Kav096 had higher frequency disturbance that corresponded to the tremor and 
higher rigidity level, which were more noticeable than the previous subject since he was 
in a further stage of the disease. The only axis that had distinguishable cycles was the Y 
axis and, thus, there was a higher peak at 1 Hz. In the other two axes, this peak was 
very reduced and others appeared at higher frequencies due to irregular movements 
during the gait cycle. There was still no peak in a higher frequency that can be distin-
guished as the frequency of the tremor, but rather a combination of the mechanical im-
pairments caused by the disease. 
Subject Kav112 had a further development of the disease and the effects of Parkinson-
ism were reflected in the frequency domain. There was a very reduced peak at 1 Hz 
characteristic of the healthy gait and there was a higher peak at 2 Hz that could be meas-
ured in all axes and both tests. This was a direct effect of the reduced arm swing caused 
by the rigidity (lower 1 Hz) and smaller faster compensatory movements (2 Hz). Tremor 
was mainly measured in X and Y axes and here there was a clear peak in which it could 
be measured, better seen in Y axis, reflecting the regularity of the movement. Tremor 
showed at a frequency of 5.5 Hz as seen in Figure 18.  
Kav042 had the highest mark in the UPDRS of the four PD subjects. Surprisingly the 
tremor was almost only felt in the X axis where practically no other component of the 
signal was recorded. This may be caused by the aid of the rollator mentioned before that 
was needed to walk. In the FFT, there was only one peak in the X axis corresponding to 
the tremor at 5 Hz. In the other two axes, the peak at 1 Hz reappeared but with a very 
low power due to the reduced movements of the subject. The small shift in the tremor 
peak compared with subject Kav112 infers that, even though the tremor was regular in 
general terms for PD, the frequency at which it occurs is slightly different to each patient. 
It can also mean that there is an effect in the tremor frequency related to the different 
stages of PD, but since there was no previous data from these subjects it couldn’t be 
evaluated statistically if the tremor frequency was altered in the development of the dis-
ease. 
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Figure 18. Time (left) and frequency (right) analysis of angular velocity data 
around the three axes from subject Kav112. 
4.2.2 Time-Frequency. 
The spectrograms of the data were performed to see the variation in frequency of each 
axis data during the tests. All the controls showed similar patterns, high power at low 
frequencies spread evenly through the whole test. The regularity of the signal showed 
the components of the healthy gait cycle were the same on each step. For control Kav175 
the Spectrogram around X axis was more disturbed but all the power of the signal was 
maintained at lower frequencies, all under 5 Hz. 
For subject Kav110 (UPDRS 1.5) signal power was spread through higher frequencies 
through the test in the X axis, from seconds 7 to 10, there was a general drop in power 
of the signal. The signals in the other two axes were very similar to the controls, cyclic 
lower frequency peaks with reduced power evenly distributed throughout the test. 
Subject Kav096 (UPDRS 2.5) got more irregular data in both tests. The messiest signal 
was shown in the X axis where there was no clear cyclic pattern. The power from the 
signal was spread through higher frequencies and the lower frequencies were reduced 
in power. Signals around the Y axis were also messier than subject Kav110 and no pat-
terns were recognizable but the power at lower frequencies was still maintained. Z axis 
signals showed lower power with some high power at low frequencies eventually but no 
discernible cyclic patterns. 
Subject Kav112 (UPDRS 3), showed no high power in the signal at high frequencies but 
there was a distinguishable high-power line that remains constant during the whole test 
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at 5Hz, characteristic of the tremor. This tremor line was more distinguishable in the Y 
axis, as it can be appreciated in Figure 19. Here, the peak at this frequency was located 
in the FFT analysis from the previous section. Z axis showed consistent power levels at 
lower frequencies in both tests but no patterns were distinguishable. 
 
Figure 19. Spectrogram of the angular velocity signal from subject Kav112. 
Subject Kav042 (UPDRS 4) had a prominent feature in the X axis, there was a constant 
line through the test at around 5 Hz that reflected the effects of the tremor, which didn’t 
show equally in the three axes. These frequencies appeared again in the Y axis but of 
smaller amplitude because the original signal wasn’t affected as much by the PD feature. 
In the Z axis, there was as a clear cyclic pattern, that, while it had less power than the 
other signals, it was clear. 
The walking tests analysis using the spectrogram proved valid to visualize the effects of 
the tremor (power of the signal around 5 Hz) and the bradykinesia (Power of the signal 
at 1-2 Hz). It also was useful to distinguish clear cyclic patterns that repeated per gait 
cycle that can be used to detect alterations on the walking patterns in frequency and 
time. No events of freezing of gait were detected in the spectrograms. 
4.2.3 RMS and Entropy. 
As mentioned in the methodology, RMS value has been used to quantitatively study 
bradykinesia in people with the disease [10]. In this study the RMS was obtained to see 
if it could also assess this feature while walking and to study if there was a pattern in the 
different stages or the disease. The results obtained are presented in table 3. 
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There was no apartment relationship between the RMS value in the X axis signal with 
the stage of PD. It seemed that the higher the UPDRS level, the higher the RMS value 
got, but it dropped for subject Kav042. The controls showed a long range of values from 
98.440 to 30.344. Around the Y axis, the RMS was always lower on the subjects with PD 
than the controls. Values ranged from 40.135 to 88.633 while the lowest value obtained 
by the study subjects was 9.921 from Kav042 and the highest was 33.172 by Kav112 
(UPDRS 3). Again, apart from the range of values, which were always lower for the PD 
subjects, there was no relationship with the stage of the disease. 
The only values that showed some relationship were the ones in the Z axis, where the 
arm swing was reflected. The Values in all the controls were notably higher than the ones 
for subjects with PD. Except of subject Kav112 (UPDRS 3), the RMS Seemed to get 
lower the higher the PD stage. 
The entropy of the signals was expected to get lower the higher the higher the stage of 
PD [11] This is due to the reduction in the amplitude of movements due to bradykinesia 
and the regular nature of the tremor, meaning that the movements in the controls would 
be more irregular and random. The results are shown in Table 4. 
 
 
 
Table 3. RMS values of every patients Suunto data. The number (Suunto 1-2) refers 
to the test number. 
Subject Test X axis Y axis Z axis 
kav110 Suunto1 21.500 22.341 49.406 
 Suunto2 21.994 22.533 44.828 
kav096 Suunto1 34.148 21.340 18.469 
 Suunto2 41.647 20.466 16.827 
kav112 Suunto1 52.250 27.407 38.851 
 Suunto2 61.528 33.172 38.454 
kav042 Suunto1 28.053 9.921 15.722 
kav113 Suunto1 79.701 61.014 149.988 
 Suunto2 98.440 73.106 182.761 
kav114 Suunto1 80.032 49.486 83.200 
 Suunto2 70.020 40.135 66.937 
kav138 Suunto1 53.144 86.657 127.727 
 Suunto2 55.710 88.633 122.249 
kav175 Suunto1 30.344 51.179 63.625 
 Suunto2 37.552 61.140 82.480 
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Subject Test X axis Y axis Z axis 
kav110 Suunto1 0.564 0.408 0.297 
 Suunto2 0.561 0.437 0.329 
kav096 Suunto1 0.790 0.560 0.723 
 Suunto2 0.746 0.508 0.705 
kav112 Suunto1 0.599 0.537 0.484 
 Suunto2 0.563 0.493 0.472 
kav042 Suunto1 0.399 0.591 0.472 
kav113 Suunto1 0.491 0.382 0.233 
 Suunto2 0.502 0.388 0.226 
kav114 Suunto1 0.578 0.368 0.300 
 Suunto2 0.552 0.379 0.310 
kav138 Suunto1 0.573 0.275 0.216 
 Suunto2 0.515 0.272 0.220 
kav175 Suunto1 0.589 0.263 0.331 
 Suunto2 0.529 0.259 0.328 
There was no apparent relationship between the UPDRS value and the normalized en-
tropy around the X and Z axis, the range of values was very similar, being the highest in 
subject Kav096 (UPDRS 2,5). Around the Y axis, all controls scored lower than PD sub-
jects. The higher the PD stage, the higher the entropy every subject scored (again higher 
scored by subject Kav096). The main score for PD subjects was 0.60, 0.50 and 0.50 for 
X, Y and Z axes respectively while controls scored a mean of 0.54, 0.33 and 0.26. 
The obtained values seemed to contradict the previous prediction and the study made 
by Rissanen et al. [11]. It has to be taken into account that their study used acceleration 
data and this one used angular velocity data. On the other hand, this study was based 
on walking tests. This means that, during the gait cycle, the healthy arm movement fol-
lowed a regular pattern, since the swinging was not altered by other movement dysfunc-
tion, thus, the regularity of the movements done by the controls lowered their scored of 
normalized entropy. Reduction of the arm swing and the appearance of the tremor should 
lower the entropy per se but, since there were other components of the signals due to 
the irregularity of their gait cycle, the overall entropy increased. 
4.2.4 Vector module. 
Treating the Suunto data at each sample as the three space coordinates (X, Y and Z) of 
the angular velocity vector, the same analysis on its module (√X2 + Y2 + Z2) seemed 
interesting. All control subjects showed distinctive cyclic patterns that stayed constant 
during both tests, which proved that the individual way of walking was reflected in the 
recorded signal. The values for the controls ranged from 160 to 400 rad/s 
Table 4. Spectral entropy of every patient’s Suunto data. The number (Suunto 1-2) 
refers to the test number. 
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All the controls showed high power of the FFT at 2 Hz, as seen in Figure 20. Control 
subject Kav114 also showed peaks at 1 Hz and Kav175 at 1 and 3 Hz of lower amplitude. 
The peaks in the FFT were at the double of the frequencies that they were when the 
signal corresponded to the three axes instead of the module. All the control spectrograms 
showed regular patterns in the lower frequencies (around 2 Hz) during the whole test. 
Control subjects Kav175 and Kav114 showed intermittent patterns that reflect the arm 
swing movement. 
 
Figure 20. Analysis of the angular velocity vector module for control subject 
Kav113. 
Kav110 (UPDRS 1.5) showed similar patterns than controls Kav114 and Kav175 but 
reduced in amplitude, reaching maximum values at 120 rad/s. The effects of the tremors 
were reduced or not visible in the signal of the module. The FFT of the signal is highly 
similar to the ones of the previous mentioned controls, with the highest peaks at 2 Hz 
and no higher frequency peaks from the tremor. The spectrogram didn’t show any com-
ponents in higher frequencies that would correspond to the effects of the tremor and no 
other remarkable modifications from the controls. 
Subject Kav096 (UPDRS 2.5) had a messier signal, with no discernible patterns or 
peaks, the maximum value of the module reached 140 rad/s but the signal was com-
pletely distorted. The spectral power didn’t show any peaks at any frequency and the 
spectrograms had instances with higher frequencies than what usually were presented 
in the rest of the signals but of lower frequencies. It has to be assumed that the perfor-
mance of the vector module for the Suunto output of this subject completely altered the 
resulting signal making no observable features. 
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Subject Kav112 (UPDRS 3), Signal was greatly altered from the controls. There is no 
discernible patterns and the maximum value obtained by the module was 175 rad/s. The 
signal’s FFT, showed a peak at 2.5 Hz and other peaks at higher frequencies (7 and 11 
Hz) but of lower power. The spectrogram showed higher frequency components of lower 
power. Although the test reflected the effects of the tremor, but didn’t seem as constant 
as it was reflected in the signal divided in the three axes. 
Subject Kav042 (UPDRS 4) had notably the most affected signal. The effects of the 
tremor were obvious and there were no recognizable patterns. The highest value ob-
tained by the vector module was 80 rad/s. The FFT of the signal was quite explanatory, 
there was a lower power peak at 2Hz and a higher power peak at 10 Hz. These power 
peaks were reflected in the spectrogram and maintained during the whole test, being 
more intense the ones at 10 Hz. If taken into account the first assumption that the FFT 
of the vector module gave peaks at the double value of frequency that the ones obtained 
in the previous sections, these peaks corresponded to the walking cyclic pattern (2 Hz) 
and the effects of the tremor (10 Hz). The RMS and the Entropy of the signals were again 
calculated and the results are presented in Table 5. 
Subject Test RMS Entropy 
kav110 Suunto1 58.330 0.514 
 Suunto2 54.783 0.538 
kav096 Suunto1 44.302 0.884 
 Suunto2 49.361 0.867 
kav112 Suunto1 70.644 0.740 
 Suunto2 79.780 0.724 
kav042 Suunto1 33.654 0.786 
kav113 Suunto1 180.476 0.347 
 Suunto2 220.083 0.331 
kav114 Suunto1 125.604 0.538 
 Suunto2 104.853 0.563 
kav138 Suunto1 163.242 0.391 
 Suunto2 160.948 0.418 
kav175 Suunto1 87.111 0.487 
 Suunto2 109.322 0.482 
The first notable thing was that the RMS values of the controls were higher than the ones 
presented in subjects with PD, with the exception of test one from control Kav175, whose 
RMS value was 87.111. There was a clear tendency to decrease the RMS value when 
the UPDRS got higher, from a score of 58.330 from subject Kav110 (UPDRS 1.5) to 
33.654 from subject Kav042 (UPDRS 4). There is an exception with subject Kav112 
(UPDRS 3) who obtained values over 70. 
Table 5.  Table containing the RMS and entropy values for the module of the angular 
velocity vector for every test. 
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Once again, the assumption made by Rissanen et al. [11] was not observed in these 
values since all PD subjects obtained a higher entropy than the controls. There was no 
apparent relation between the stage of the disease and the level of entropy since the 
lowest values were obtained by subject Kav110 (UPDRS 1.5) and the highest ones by 
subject Kav096 (UPDRS 2.5). 
Overall the calculation of the angular velocity vector module only gave some results re-
garding the visualization of patterns while walking and how the tremor and the bradyki-
nesia affected the signals. No optimal measurement of the tremor was achieved, with 
the exception of subject Kav042, since most of the PD signals turn out messier and both 
their FFT and spectrogram were more difficult to interpret. The entropy value of the sig-
nals seemed always higher in the PD subjects but no correlation with the level of the 
disease was detected. There was a clear pattern regarding the RMS value of the signals, 
which got lower the higher the UPDRS value. This is because, since the movements of 
people with parkinsonism are reduced in amplitude and affected by higher frequency 
tremors, that relates in the signal as lower amplitude that the ones generated from the 
natural movement. The overall signal suffered a reduction in its variation during the gait 
cycle, the opposite than the controls signals which reflected higher amplitude of move-
ments and, thus, a greater variation. 
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5. CONCLUSIONS 
There has been already a number of studies assessing the detection or diagnosis of 
Parkinson’s Disease using wearable devices [17]-[18] [20]-[21] [24]-[29]. This technology 
allows a new form of evaluation of the features that encompass the disease. The main 
problem regarding the assessment of the disease is the lack of daily data that can be 
provided to the healthcare professionals since the tests regarding the evaluation of the 
disease are performed in long time intervals. This information is usually provided by fam-
ily members, professional personnel taking care of him/her or the patient themselves, 
which does not provide an objective input on the stage of the disease. Another lack of 
information comes from the specific response to levodopa dosage. It should be individ-
ually measured since it can vary from patient to patient, so that the treatment can be 
effectively applied. The use of long-term wearable devices provides a solution to this 
problem since they can measure specific parameters during extended periods of time, 
detecting how PD affects the signals measured by the devices. The interpretation of 
these data by the healthcare professionals is key to properly assess the stage of the 
disease in which patients are and provide a proper treatment. 
The use of the Forciot insole and the Suunto gyroscopic devices provides a good solution 
to the problem. These devices are worn with minimally invasiveness or discomfort. For-
ciot insole provides a good visualization of the walking patterns of the wearer and gives 
a result of the distribution of forced during the phases of the human gait cycle. The study 
showed the reduction of the force applied against the ground by the subjects with PD, 
especially during the toe-off phase, at the end of the cycle.  
Suunto gyroscopes were especially useful in the visualization of walking patterns in the 
arm swing and the effects of bradykinesia and tremor on the signals. Frequency analysis 
were useful to assess the frequency components of the signals and more specifically to 
the tremor detection. Spectrogram analysis was also useful detecting the tremor in peri-
ods of time. This would be especially useful in long term signals where the severity of 
the movement disorders fluctuates from one day to another. RMS values only proved 
quality results regarding the stage of the disease when performed on the module of the 
angular velocity vector rather than the signals separated by each axis. Normalized en-
tropy values didn’t give any input on the UPDRS level of the subjects, thus proving to be 
an ineffective measurement with gyroscopic signals of walking tests. 
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The application of wearable devices to visualize the motor features of PD provide a 
promising solution to the monitoring of people suffering the disease. The low cost of this 
kind of technology makes it more available to the public use and it makes possible to 
perform population-based epidemiological researches that other technologies do not 
achieve such as medical imaging methods. 
Since the data used in this study was obtained from a 20-step walking test performed at 
the clinic for a small subset of eight people, there was no way to compare the effect of 
PD during different stages of the disease for the same patient. This could be used to 
assess specific alterations in the movement of each patient individually which would be 
a used to distinguish the specific patterns of a subject and compare it to the effects of 
parkinsonism. 
The use of the Forciot smart insole and the Suunto Movesense gyroscopic sensor proved 
to be useful distinguishing some motor features of parkinsonism during different stages 
of the disease and proved to be a possible solution to the home monitoring problem 
reducing as much as possible the discomfort that could be generated. There should be 
further studies in order to find an optimal solution and the most efficient methods that 
could be used with these wearable devices. 
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APPENDIX A: FIGURES 
Cut data: Forciot data (N) together with the Suunto data (rad/s) plotted together per tests, first two from test 1 and last two from test 2, against time. 
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Cut Suunto data per axis: Angular velocity measured around the three axes, X (top), Y (center) and Z (bottom). 
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Forciot total input data: Total input data measured from Forciot insole (N). Test 1 (top) and test 2 (bottom). 
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Suunto data analysis: Suunto data (rad/s) around the three axes. Time domain (left), frequency domain (right). 
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Suunto Spectrograms: Spectrograms of the angular velocity around the three axes, X (top), Y (center) and Z (bottom). 
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Suunto module: Representation of the angular velocity module in time domain (top), frequency domain (center) and its spectrogram (bottom). 
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APPENDIX B: ETHIC, SOCIAL, ECONOMIC AND 
ENVIRONMENTAL ASPECTS. 
This appendix contains a brief explanation of some of the impacts that the subject of this 
thesis can have on ethical, social, economic and environmental aspects. 
B.1 Introduction 
Parkinson’s disease is the second most common neurodegenerative disease. The symp-
toms encompass a range of features that go from motor disabilities to affect the patient’s 
cognition. Even though there is no definite cure, there are treatments that help managing 
the symptoms in order to make life easier for the people suffering it by, for example, 
reducing the risk of accidents. The most common one is the treatment with levodopa. 
One of the greatest challenges is the correct application of the levodopa dosage since 
the severity of the symptoms is very variable by days (or even within the same one) and 
the inputs the clinicians have are from tests performed in the appointments with the pa-
tient, which is not representative of the state of the disease. Proper daily monitoring is a 
need in order to provide a more sufficient input on the state of the patient and the re-
sponse to the treatment (i.e. the state before and after the levodopa dosage). Wearable 
technology can provide the information needed due to its low cost, and their higher com-
fort than bigger hospital devices. 
This project uses a pressure sensitive insole and a gyroscopic sensor in the wrist of the 
subjects (4 in different stages of PD and 4 controls) to see if the motor symptoms of the 
disease can be detected and measured by the devices in a 20-step walking test. The 
interpretation of the data would be key for the clinicians to understand the stage of PD 
the patient is in. 
B.2 Impact description related with the project 
The main impacts related with this study can be classified as: 
Social: Monitoring can be used to provide a more personalized treatment through medi-
cation and physiotherapy. This will result in an improvement the daily living activities 
performed by the patients. 
Economic. The use of wearable technology in the assessment of PD motor symptoms 
can reduce the cost of the monitoring of the patients by having more thorough observa-
tion without increasing the number of visits to the hospital. 
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Ethical: The main ethical impact is the fact that in this project data is obtained from tests 
taken from human beings with Parkinson’s Disease. Full consent is needed. There is 
another concern with the property of the data and the accessibility. Data was collected 
securely and remotely, without compromising the patient’s privacy. 
B.3 Expanded analysis of some of the impacts. 
The daily monitoring can affect each patient’s lives making more effective the treatment 
they are following, improving their daily life. They would be less dependent on the per-
sonal check ups and eventually, the data could be sent directly to the clinicians making 
the visit to the hospital less necessary. 
As mention before, the use of wearable technology reduces the cost of the assessment 
of motor symptoms via more expensive hospital devices and the reduction of visits to the 
hospital reduces the overall price to treat the patient. Improving the effectiveness also 
reduces the cost in the dosage of levodopa since it avoids the use of extra dosage. 
On the ethical part it should be noted that special care has to be taken because the study 
is based on data from PD patients. The project this study is based on was performed 
following the Ethical Principles for Medical Research Involved Human Subjects, revised 
version in 2013 of the World medical Association Declaration of Helsinki, Finland, in 
1964. The data was coded and did not contain any kind of identifying information, to 
maintain the privacy of the subjects. The National Supervisory Authority of Welfare and 
Health in Helsinki (Valvira) approved the devices used in the study in April of 2018 and 
the study protocol was approved from the Ethics Committee of the Hospital District of 
Southwest Finland in Turku. 
B.3 Conclusion 
The socioeconomic impact of this project is not direct but rather is based on the effects 
it would have. The devices don’t help in any direct manner to the daily living of the pa-
tients but they suppose a tool for better monitoring that would improve the personaliza-
tion of the treatment and, thus, its effectiveness.  
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APPENDIX C: ECONOMIC BUDGET 
This appendix contains an estimation of the budget that would be necessary to Perform this thesis taking into account direct and indirect 
costs. It takes into account that the average salary of person with a degree in Finland would be paid 20 €/h and the general tax is 24%. The 
thesis took about six months to perform. Since it is of 12 ECTS, it corresponds to approximately 325 hours of work.  
WORKFORCE COST (Direct Cost) Hours Salary/hour Total 
 325 20 € 6500 € 
 
RESOURCE MATERIAL COSTS (Direct Costs) 
Purchase 
price 
Use (months) 
Amortization 
(years) 
Total 
Personal computer (Software included) 1300 € 6 4 162.50 € 
Suunto Movesense ® gyroscope sensors 40 € 12 2 20 € 
Smart insole Forciot ® 1000 € 12 2 500 € 
 
TOTAL MATERIAL COSTS 682.50 € 
 
GENERAL EXPENSE (Indirect Costs) 15% Over DC 1077.38 € 
INDUSTRIAL BENEFIT 6% Over DC+IC 495.59 € 
 
SUBTOTAL BUDGET 8755.47 € 
APLICABLE TAX 24% 2101.31 € 
 
TOTAL BUDGET 10856.78 € 
 
